title: [Prostagut forte treatment of patients with prostatic adenoma with comorbid chronic prostatitis].
abstract: The study consisting of four visits included 69 patients with prostatic adenoma and concomitant chronic prostatitis. The patients received either monotherapy with an alpha adrenoblocker or combined treatment including phytodrug prostagut forte. The results of the study showed that the above combined treatment produces more pronounced and persistent improvement of urodynamic indices, leads to reduction of leukocyte count in the urine and prostatic secretion, upgrades quality of life. The absence of side effects allows recommendation of prostagut forte for treatment of presenile and senile patients with prostatic adenoma and associated pathology.
authors.forename: V P
authors.initials: VP
authors.lastname: Avdoshin
authors.forename: S A
authors.initials: SA
authors.lastname: Pul'bere
mesh_terms: D000328:Adult; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D028321:Plant Preparations / Q000008:administration & dosage* / Q000009:adverse effects; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D011472:Prostatitis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D011788:Quality of Life; D014563:Urodynamics / Q000187:drug effects*
chemical_list: D028321:Plant Preparations; C574901:Prostagut forte